Environmental triggers of thyroiditis: hepatitis C and interferon-α

Area of Science:

• Endocrinology
• Virology
• Immunology

Background:

• Autoimmune thyroid diseases (AITD) result from complex genetic and environmental interactions.
• Hepatitis C virus (HCV) infection and interferon-alfa (IFNα) therapy are increasingly recognized as triggers for AITD.
• The exact mechanisms by which HCV and IFNα induce AITD are not fully understood but may involve synergistic immune stimulation and direct thyroid toxicity.

Purpose of the Study:

• To investigate the association between HCV infection, IFNα therapy, and the development of AITD.
• To highlight the clinical manifestations and management of interferon-induced thyroiditis (IIT).
• To recommend screening protocols for patients undergoing IFNα therapy for HCV.

Main Methods:

• The study reviews existing data on the interplay between HCV, IFNα, and thyroid autoimmunity.
• Analysis of clinical presentations of IIT, including non-autoimmune and autoimmune thyroiditis.
• Evaluation of the frequency of IIT in HCV patients receiving IFNα therapy.

Main Results:

• Approximately 40% of HCV patients develop clinical or subclinical thyroid disease during IFNα therapy.
• Interferon-induced thyroiditis (IIT) can manifest as Graves' disease, Hashimoto's thyroiditis, or destructive thyroiditis.
• Routine thyroid function screening is effective in diagnosing IIT in HCV patients on IFNα.

Conclusions:

• Interferon-induced thyroiditis is a common complication in HCV patients treated with IFNα.
• Early diagnosis through thyroid function screening is crucial to prevent complications like thyrotoxicosis.
• Standard treatments for specific thyroid manifestations are recommended, but anti-thyroid drugs should be avoided due to potential hepatotoxicity.